Loss of Nitric Oxide Induces Fibrogenic Response in Organotypic 3D Co-Culture of Mammary Epithelia and Fibroblasts-An Indicator for Breast Carcinogenesis.
arginine
desmoplasia
extracellular matrix
fibroblasts
mammary epithelial cells
mammary gland
mammary morphogenesis
myofibroblasts
nitric oxide
organotypic 3D co-culture
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
05 Jun 2021
05 Jun 2021
Historique:
received:
27
04
2021
revised:
28
05
2021
accepted:
02
06
2021
entrez:
2
7
2021
pubmed:
3
7
2021
medline:
3
7
2021
Statut:
epublish
Résumé
Excessive myofibroblast activation, which leads to dysregulated collagen deposition and the stiffening of the extracellular matrix (ECM), plays pivotal roles in cancer initiation and progression. Cumulative evidence attests to the cancer-causing effects of a number of fibrogenic factors found in the environment, diseases and drugs. While identifying such factors largely depends on epidemiological studies, it would be of great importance to develop a robust in vitro method to demonstrate the causal relationship between fibrosis and cancer. Here, we tested whether our recently developed organotypic three-dimensional (3D) co-culture would be suitable for that purpose. This co-culture system utilizes the discontinuous ECM to separately culture mammary epithelia and fibroblasts in the discrete matrices to model the complexity of the mammary gland. We observed that pharmaceutical deprivation of nitric oxide (NO) in 3D co-cultures induced myofibroblast differentiation of the stroma as well as the occurrence of epithelial-mesenchymal transition (EMT) of the parenchyma. Such in vitro response to NO deprivation was unique to co-cultures and closely mimicked the phenotype of NO-depleted mammary glands exhibiting stromal desmoplasia and precancerous lesions undergoing EMT. These results suggest that this novel 3D co-culture system could be utilized in the deep mechanistic studies of the linkage between fibrosis and cancer.
Identifiants
pubmed: 34198735
pii: cancers13112815
doi: 10.3390/cancers13112815
pmc: PMC8201212
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : University of Toledo
ID : 110794
Organisme : Ohio Cancer Research
ID : 5017
Organisme : American Cancer Society
ID : RSG-18-238-01-CSM
Organisme : Wellcome Trust
ID : 206298
Pays : United Kingdom
Organisme : NCI NIH HHS
ID : R01 CA248304
Pays : United States
Organisme : NCI NIH HHS
ID : R01CA248304
Pays : United States
Références
Hypertension. 2013 Dec;62(6):1003-4
pubmed: 24060893
Cell Rep. 2019 Apr 2;27(1):213-225.e5
pubmed: 30943403
Am J Pathol. 2013 Jun;182(6):2147-54
pubmed: 23684430
Breast Cancer Res. 2014 Oct 15;16(5):453
pubmed: 25315014
Proc Natl Acad Sci U S A. 1987 Aug;84(16):5763-7
pubmed: 3039506
Curr Opin Cell Biol. 2014 Feb;26:87-95
pubmed: 24529250
Cancer Res. 1987 Jul 1;47(13):3425-9
pubmed: 3034415
J Biol Chem. 2003 Jun 20;278(25):22546-54
pubmed: 12692136
Int J Mol Sci. 2018 Nov 20;19(11):
pubmed: 30463366
Elife. 2018 Mar 21;7:
pubmed: 29560860
Biophys J. 2006 Dec 15;91(12):4665-77
pubmed: 17130233
Nat Protoc. 2015 Dec;10(12):2027-53
pubmed: 26584444
Oncotarget. 2016 Jul 5;7(27):42385-42392
pubmed: 27285753
Oncogene. 2008 Jun 19;27(27):3875-9
pubmed: 18246119
Cancer Metastasis Rev. 2016 Dec;35(4):655-667
pubmed: 27914000
J Clin Invest. 2009 Jun;119(6):1420-8
pubmed: 19487818
Cancer Res. 2002 Mar 1;62(5):1450-7
pubmed: 11888919
Curr Biol. 2017 Mar 20;27(6):R207-R211
pubmed: 28324731
Cell. 2017 Nov 30;171(6):1397-1410.e14
pubmed: 29107331
Pediatr Res. 1998 Aug;44(2):197-200
pubmed: 9702914
Nat Protoc. 2012 Jan 12;7(2):235-46
pubmed: 22240585
Sci Rep. 2019 Apr 30;9(1):6688
pubmed: 31040372
Blood. 2003 Jan 15;101(2):498-507
pubmed: 12393416
Int J Mol Sci. 2019 Sep 03;20(17):
pubmed: 31484418
Am J Physiol Lung Cell Mol Physiol. 2007 Sep;293(3):L525-34
pubmed: 17631612
J Natl Cancer Inst. 1981 Aug;67(2):335-45
pubmed: 6267343
Cell Death Differ. 2011 Sep;18(9):1470-7
pubmed: 21617693
N Engl J Med. 1986 Dec 25;315(26):1650-9
pubmed: 3537791
Antioxidants (Basel). 2019 Sep 17;8(9):
pubmed: 31533268
J Cardiovasc Pharmacol. 2011 Apr;57(4):376-9
pubmed: 21297493
Eur J Cell Biol. 2004 Dec;83(11-12):631-45
pubmed: 15679108
Methods. 2003 Jul;30(3):256-68
pubmed: 12798140
NPJ Microgravity. 2017 Feb 28;3:10
pubmed: 28649632
Cancer Discov. 2012 Sep;2(9):772-4
pubmed: 22969116
Biomaterials. 2020 Apr;238:119853
pubmed: 32062146
Proc Natl Acad Sci U S A. 2005 Jun 14;102(24):8758-63
pubmed: 15939886
Int J Vasc Med. 2012;2012:918267
pubmed: 22611498
Nanomaterials (Basel). 2018 Feb 18;8(2):
pubmed: 29463042
Cell Biol Int. 2016 Jul;40(7):750-60
pubmed: 27063575
Nature. 2004 Nov 18;432(7015):332-7
pubmed: 15549095
Curr Opin Clin Nutr Metab Care. 2013 Jan;16(1):76-82
pubmed: 23164986
Nat Rev Mol Cell Biol. 2019 Feb;20(2):69-84
pubmed: 30459476
Methods Mol Biol. 2017;1501:217-231
pubmed: 27796955
Cancer Discov. 2019 Jul;9(7):837-851
pubmed: 30992279
Science. 2006 Oct 13;314(5797):298-300
pubmed: 17038622
Transl Res. 2019 Jul;209:55-67
pubmed: 30871956
Acta Cir Bras. 2009 Mar-Apr;24(2):107-11
pubmed: 19377778
Am J Pathol. 2007 Jun;170(6):1807-16
pubmed: 17525249
Dis Model Mech. 2011 Mar;4(2):165-78
pubmed: 21324931
World J Gastroenterol. 2005 Oct 28;11(40):6385-8
pubmed: 16419170
Lab Invest. 1993 Jun;68(6):696-707
pubmed: 8515656
J Pharmacol Exp Ther. 2013 Oct;347(1):117-25
pubmed: 23912334
Cold Spring Harb Symp Quant Biol. 2005;70:383-8
pubmed: 16869775
J Nephrol. 2014 Jun;27(3):281-7
pubmed: 24446346
Cell Metab. 2013 Oct 1;18(4):470-7
pubmed: 23954640
Am J Pathol. 2015 Jun;185(6):1769-82
pubmed: 25913075
Biochem Biophys Res Commun. 1993 Dec 15;197(2):523-8
pubmed: 7505570
Cancer Causes Control. 1997 May;8(3):491-503
pubmed: 9498906
iScience. 2019 Sep 27;19:388-401
pubmed: 31419632
Am J Physiol Lung Cell Mol Physiol. 2007 Jul;293(1):L212-21
pubmed: 17496059
Sci Rep. 2019 May 10;9(1):7250
pubmed: 31076601
Cancer Cell. 2008 May;13(5):394-406
pubmed: 18455123
J Androl. 2012 Sep-Oct;33(5):805-10
pubmed: 22207705
Nat Methods. 2007 Apr;4(4):359-65
pubmed: 17396127
Differentiation. 1991 Apr;46(3):209-21
pubmed: 1833254
Annu Rev Pathol. 2013 Jan 24;8:161-87
pubmed: 23347351
Bio Protoc. 2019 Oct 05;9(19):e3392
pubmed: 33654884
Br J Pharmacol. 1996 Jul;118(6):1433-40
pubmed: 8832069
Development. 1998 Apr;125(7):1315-24
pubmed: 9477330
J Geriatr Cardiol. 2011 Dec;8(4):230-42
pubmed: 22783310
Cancer Res. 2019 Jun 15;79(12):3139-3151
pubmed: 30992322
Cell Adh Migr. 2012 May-Jun;6(3):203-19
pubmed: 22568985
Mol Cancer Res. 2015 Jun;13(6):1034-43
pubmed: 25724429
Biomaterials. 2020 Jul;247:119975
pubmed: 32278213
Arterioscler Thromb Vasc Biol. 2006 Nov;26(11):2439-44
pubmed: 16946131
Am J Pathol. 1982 Sep;108(3):276-83
pubmed: 6287844
BMC Med. 2008 Apr 28;6:11
pubmed: 18442412
Am J Pathol. 2017 Aug;187(8):1787-1799
pubmed: 28627413
Sci Rep. 2018 Aug 9;8(1):11920
pubmed: 30093732
Trends Cell Biol. 2015 Nov;25(11):675-686
pubmed: 26437589
Methods Mol Biol. 2013;945:193-219
pubmed: 23097109
Amino Acids. 2009 May;37(1):89-95
pubmed: 18683019
Clin Cosmet Investig Dermatol. 2014 Nov 06;7:301-11
pubmed: 25395868
Proc Natl Acad Sci U S A. 2004 Apr 6;101(14):4966-71
pubmed: 15051869
J Enzyme Inhib Med Chem. 2002 Aug;17(4):267-70
pubmed: 12530480
J Cell Sci. 2008 Apr 15;121(Pt 8):1141-50
pubmed: 18388309
Biochim Biophys Acta Mol Basis Dis. 2017 Jan;1863(1):298-309
pubmed: 27825850
Int J Mol Sci. 2019 May 07;20(9):
pubmed: 31067787
Oncogene. 2000 Sep 7;19(38):4337-45
pubmed: 10980609
Virchows Arch A Pathol Anat Histopathol. 1985;408(1):49-59
pubmed: 3933171
J Pathol. 2003 Jul;200(4):429-47
pubmed: 12845611
Cell Death Dis. 2014 Jun 26;5:e1302
pubmed: 24967964
J Clin Invest. 2003 Apr;111(8):1201-9
pubmed: 12697739
J Natl Cancer Inst. 1995 Jul 5;87(13):964-73
pubmed: 7629883
Breastfeed Med. 2011 Dec;6(6):393-9
pubmed: 20958096
Cancers (Basel). 2016 Jan 27;8(2):
pubmed: 26828520
Breast Cancer Res. 2005;7(5):190-7
pubmed: 16168137
EMBO Rep. 2014 Dec;15(12):1243-53
pubmed: 25381661